BIO-key International, Inc. (BKYI) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed picture. Financial performance shows a slight decline in gross margin and increased net loss, but cash position improved significantly. Product development is positive with new contracts and high-quality offerings. Market strategy is strong with potential expansions and partnerships. However, flat revenues and management's vague responses in the Q&A raise concerns. The strategic plan indicates optimism for future growth, but immediate financial metrics and unclear guidance limit positive sentiment. Overall, the stock reaction is likely neutral in the short term, balancing positive long-term prospects with current challenges.
Key Financial Performance
Q3 2025 Revenue $1.55 million, down approximately $595,000 year-over-year (from $2.1 million in Q3 2024). The decrease is attributed to the absence of large orders from Q3 2024, which accounted for $665,000 of the year-over-year difference, partially offset by new orders.
Year-to-date Revenue 2025 Slightly under $5 million, down approximately $600,000 year-over-year. The decline is due to quarter-to-quarter variability from the timing of larger customer orders.
License Fee Revenue Q3 2025 $918,000, down from $1.4 million in Q3 2024. The decline is due to the absence of large orders from Q3 2024.
Service Revenue Q3 2025 $268,000, slightly up from $267,000 in Q3 2024. Growth in recurring service revenue offset the decline in customer service revenue from large customer upgrades in Q3 2024.
Hardware Sales Q3 2025 $364,000, down from $436,000 in Q3 2024. The decline is due to the timing of hardware shipments for ongoing customer rollouts, partially offset by the sale of fully reserved inventory.
Gross Margin Q3 2025 77%, slightly down from 78% in Q3 2024. The change is due to the absence of third-party license software offsetting a lower portion of license revenue.
Operating Expenses Q3 2025 $2.1 million, down 8% from $2.3 million in Q3 2024. This reflects a 13% decrease in SG&A expenses, offset by a 5% increase in R&D expenses for product development.
Net Loss Q3 2025 $965,000 or $0.15 per share, compared to $739,000 or $0.39 per share in Q3 2024. The increase in net loss is due to lower revenues, partially offset by reduced operating expenses.
Net Loss First 9 Months of 2025 $2.9 million or $0.50 per share, unchanged from $2.9 million in the same period of 2024, but the per-share loss decreased due to a higher number of shares outstanding.
Cash Position as of September 30, 2025 $2 million, up from $438,000 at year-end 2024. The increase is due to financing activities, including a senior secured promissory note and warrant exercises.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
PortalGuard Version 7: A significant update to the PortalGuard identity platform, featuring platform modernization, enhanced configurability, and improved deployment capabilities. Expected general availability is late Q1 or early Q2 2026.
EcoID III Fingerprint Scanner: New FBI FAP 20 certified fingerprint scanner aimed at regulated industries. Features encrypted device-to-host communications and liveness detection for secure authentication. Initial orders delivered to defense and government customers in Q3.
Defense Sector Expansion: Momentum gained in the defense sector with deployments in two of the top four largest global defense agencies. Focus on biometrics for critical infrastructure and sensitive environments.
European, Middle East, and Africa (EMEA) Market: Advancing channel sales efforts in EMEA regions, focusing on BIO-key branded solutions.
Cost Reduction: Operating expenses reduced by over 10% in the first 9 months of 2025, supporting the goal of positive cash flow and profitability.
Marketing Overhaul: Engaged an external marketing firm for new website content and targeted strategies. Major website overhaul planned for release before the Gartner IAM Conference in December.
Cyber Defense Initiative: Launched in response to increased global defense spending, particularly in Europe and the Middle East. Focus on cyber resiliency and security.
Funding and Liquidity: Raised approximately $3 million through a warrant exercise transaction, significantly expanding cash liquidity to pursue growth.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Revenue Variability: The company experienced a $600,000 decrease in year-to-date revenue compared to the previous year, attributed to the timing of larger customer orders. This variability creates challenges in forecasting and maintaining consistent financial performance.
Seasonal Revenue Impact: Q3 is generally a slower period, particularly in Europe due to the summer holiday season, which affects revenue generation.
Dependence on Large Customers: The company relies heavily on a few large customers for significant portions of its revenue. Delays in renewals or expansions from these customers can adversely impact financial performance.
Product Development and Testing: The company is in the final stages of developing and testing new products, such as PortalGuard Version 7 and EcoID III. Delays or issues in development or security testing could impact product launch timelines and revenue.
Market Competition: The company operates in a competitive market, particularly in the cybersecurity and biometric authentication sectors, which could impact its ability to secure new contracts and retain existing customers.
Economic and Regulatory Risks: Economic uncertainties and stringent regulatory requirements in industries like defense, banking, and healthcare could pose challenges to market expansion and compliance.
Cash Flow and Profitability: Despite reducing operating expenses, the company is not yet profitable and faces challenges in achieving positive cash flow, which could impact its ability to invest in growth initiatives.
Hardware Sales Decline: A decline in hardware sales, attributed to the timing of shipments, could impact overall revenue and profitability.
Inventory Risks: The company has $2.8 million in fully reserved inventory, which poses a risk if potential customers do not materialize.
Funding Dependence: The company raised $3 million through a warrant exercise transaction, which improves liquidity but indicates a reliance on external funding to support operations and growth.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Customer Contract Renewals: The company expects its large banking customer to renew their subscription contract in early 2026, with potential business and renewal revenue of $1 million to $3 million in the first quarter of 2026. The customer has over 29 million users enrolled in the solution, with potential for meaningful future additions.
PortalGuard Identity Platform Update: The company plans to release a significant update to its PortalGuard identity platform (Version 7) in late Q1 or early Q2 of 2026. This update will include major platform modernization, enhanced configurability, and improved deployment capabilities.
New Product Launch - EcoID III Fingerprint Scanner: The company introduced the FBI FAP 20 certified EcoID III fingerprint scanner in Q3 2025, aimed at regulated industries. It expects government-related and highly regulated industries like financial services, higher education, and healthcare to adopt this new product.
Cyber Defense Initiative: The company is advancing its cyber defense initiative, targeting increased global defense spending, particularly in Europe and the Middle East. It expects a growing base of new contract activity and deployments in the defense sector.
Market Expansion and Marketing Efforts: The company is finalizing a major website overhaul and new marketing messaging to be implemented in Q4 2025. This is aimed at positioning the company for growth in 2026, particularly in the Europe, Middle East, and Africa regions.
Financial Position and Growth Prospects: The company raised approximately $3 million in net proceeds through a warrant exercise transaction, significantly expanding its cash liquidity. It expects a strong close to 2025 and is well-positioned for growth and achieving objectives in 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Was the Bank of Egypt deal a recurring revenue deal or permanent licenses?
A:The Bank of Egypt deal was an initial deployment announced about 10 months ago, and it is expected to expand further, possibly in the fourth quarter. It is a growing deployment.
Q:Does partnering with Raya on the Bank of Egypt project lower margins?
A:No, the gross margins on software remain at 90-plus percent. Partnering with companies like Raya is seen as a force multiplier, bringing local market expertise and significant opportunities.
Q:Is the non-employee expansion for the Bank of Egypt project targeted for 2027?
A:The initial deployment covered about 20,000 users, not the full employee base. Employee expansion is on the table for this year, and CIAM (Customer Identity and Access Management) deployment is expected to begin in 2026.
Q:Is the new defense contract in the Middle East on the same scale as the previous defense ministry contract?
A:The new defense contract is even larger with significant expansion potential. These deals are large, have a long tail, and are very sticky.
Q:What is the current ARR (Annual Recurring Revenue)?
A:The ARR is in the $6 million to $7 million range, including renewals on traditional contracts. Churn is in the single-digit range.
Q:Is the price of the EcoID III scanner lower than EcoID II, and how does it compare in quality?
A:The EcoID III scanner is priced at $49.99, slightly higher than EcoID II at $44.99, but it offers higher quality with liveness detection and full encryption. It competes with higher-quality devices like the PIVPro at a lower price point.
Q:Is there an update on the value of the boomerang stock received a year ago?
A:The value appears to be intact, with the company involved in small acquisitions and strategic scenarios. A detailed update will be available during the audit for fiscal 2025.
Q:What is driving the high trading volume of the stock?
A:Announcements and interest in the security space are likely driving the volume. However, the exact reasons for trading 450 million shares in a single day are unclear.
Q:What led to the decision to provide formal guidance, and will there be guidance for 2026?
A:Confidence in the pipeline and results from investments in the partner network led to the decision. Formal guidance for 2026 may be provided as predictability improves.
Q:Is the large renewal in 1Q 2026 still on track?
A:Yes, the large renewal in 1Q 2026 is still on track.
Q:Did the U.S. government shutdown impact the business?
A:No, the U.S. government shutdown did not impact the business.
Q:Are there other major renewals or expansion opportunities in 2026?
A:Yes, there are major renewals and expansion opportunities in defense, banking, and healthcare, as well as expansions in existing deployments like the National Bank of Egypt.
Q:What is the status of the Channel Alliance Program (CAP)?
A:The CAP is growing with significant partners who provide local expertise and credibility. The focus is on quality over quantity, and some partners exclusively sell BIO-key solutions.
Q:Are operating expenses expected to change, and is profitability on the horizon?
A:Operating expenses are being carefully managed, and profitability is expected due to a strong pipeline, large renewals, and efficient scaling through the CAP Program.
Q:Why are revenues flat or down year-over-year?
A:Revenues are flat due to the transition from third-party to BIO-key products and an anomaly last year with a banking customer catching up on payments. Timing issues also contributed.
Q:Review of Unclear Management Responses
A:Management avoided giving a direct answer regarding the high trading volume of the stock, stating only theories without concrete reasons. Additionally, the update on the boomerang stock value lacked detailed information, with specifics deferred to the fiscal 2025 audit.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Africa region
Biometrics positive
CC review
Ceci financials
Ceci number
Conference mid
Conference reminder
Development week
East success
EcoID III
EcoID fingerprint
MFA
ability
addition
banking customer
content
customer order
cyber
date
defense budget
defense industry
deployment solution
device
education
government
initiative
marketing
messaging
method
multifactor authentication
option
reader
renewal
security defense
spending
timing
transaction
variability
website
BKYI Transcript
BIO-key International, Inc. (BKYI) Q1 2026 Earnings Call Transcript
Positive5-18
The earnings call reveals strong revenue growth expectations, improved net loss, and positive market trends in authentication solutions. Product developments and strategic focuses align with market needs, and financial health is stable with no funding issues. The Q&A session highlights optimism for future opportunities and a strong pipeline, despite some challenges in U.S. contracts. Overall, the positive elements outweigh the negatives, suggesting a likely positive stock price movement.
BIO-key International, Inc. (BKYI) Q4 2025 Earnings Call Transcript
Positive3-31
The earnings call highlights improved financial metrics, including increased gross margins and cash position, despite a slight increase in net loss. The Q&A reveals optimistic guidance with potential growth in strategic sectors and regions, supported by partnerships. The announcement of PortalGuard Version 7 and a significant contract renewal further bolster the outlook. While some uncertainties remain, such as the reverse stock split, the overall sentiment leans positive due to strong future prospects and strategic initiatives.
BIO-key International, Inc. (BKYI) Q3 2025 Earnings Call Transcript
Unknown11-14
The earnings call presents a mixed picture. Financial performance shows a slight decline in gross margin and increased net loss, but cash position improved significantly. Product development is positive with new contracts and high-quality offerings. Market strategy is strong with potential expansions and partnerships. However, flat revenues and management's vague responses in the Q&A raise concerns. The strategic plan indicates optimism for future growth, but immediate financial metrics and unclear guidance limit positive sentiment. Overall, the stock reaction is likely neutral in the short term, balancing positive long-term prospects with current challenges.
BIO-key International, Inc. (BKYI) Q2 2025 Earnings Conference Call Transcript
Positive8-13
The earnings call highlights strong revenue growth (49% increase), reduced SG&A expenses, and a significant reduction in note payable. Despite a slight decline in gross margin, the overall financial performance is robust. The Q&A section reveals confidence in future growth, especially in defense and cybersecurity markets. Although management avoided specific guidance, the positive contract activity and expected breakeven achievement provide a positive outlook. The lack of market cap data suggests a neutral to positive reaction, but given the strong financials and growth prospects, a positive sentiment is warranted.
BKYI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
